Top News

Hyalozyme Therapeutics Finds $9.2M

San Diego-based Hyalozyme Therapeutics has raised a third round of funding from Grove Capital, Cimmaron Biomedical Investors, Richie Capital, and Colt Ventures. Hyalozyme is developing recombinant therapeutic enzymes. More information »


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel